Johannes Levin

Johannes Levin, MD, is Professor of Clinical Neurodegeneration at the Department of Neurology, LMU Munich, and coordinator of clinical research at the German Center for Neurodegenerative Diseases (DZNE) in Munich. In addition, he serves as part-time Chief Medical Officer of MODAG GmbH. His clinical and research work focuses on neurodegenerative diseases, particularly synucleinopathies and genetically determined forms of dementia. His translational research addresses protein aggregation, biomarker development, natural history, and disease-modifying therapies. He is involved in several international cohort studies and clinical trial networks and is leading translational and clinical development programs targeting pathological protein aggregation, including the development of anle138b/emrusolmin.